These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Asthma in children less than 5 years of age: eosinophils and serum levels of the eosinophil proteins ECP and EPX in relation to atopy and symptoms. Zimmerman B, Enander I, Zimmerman R, Ahlstedt S. Clin Exp Allergy; 1994 Feb; 24(2):149-55. PubMed ID: 8187030 [Abstract] [Full Text] [Related]
3. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma. Wever AM, Wever-Hess J, Hermans J. Clin Exp Allergy; 1997 May; 27(5):519-29. PubMed ID: 9179426 [Abstract] [Full Text] [Related]
5. Clinical value of monitoring eosinophil activity in asthma. Koller DY, Herouy Y, Götz M, Hagel E, Urbanek R, Eichler I. Arch Dis Child; 1995 Nov; 73(5):413-7. PubMed ID: 8554357 [Abstract] [Full Text] [Related]
6. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy. Scher H, Berman D, Weinberg EG, Schinkel M, Peper B, Chalton DO, Potter PC. Clin Exp Allergy; 1996 Oct; 26(10):1131-41. PubMed ID: 8911698 [Abstract] [Full Text] [Related]
7. Eosinophils and eosinophil-derived proteins in children with moderate asthma. Hoekstra MO, Hovenga H, Gerritsen J, Kauffman HF. Eur Respir J; 1996 Nov; 9(11):2231-5. PubMed ID: 8947065 [Abstract] [Full Text] [Related]
8. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment. Kristjánsson S, Strannegård IL, Strannegård O, Peterson C, Enander I, Wennergren G. J Allergy Clin Immunol; 1996 Jun; 97(6):1179-87. PubMed ID: 8648010 [Abstract] [Full Text] [Related]
11. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. Pedersen B, Dahl R, Larsen BB, Venge P. Allergy; 1993 Jul; 48(5):377-82. PubMed ID: 8103646 [Abstract] [Full Text] [Related]
13. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Pedersen B, Dahl R, Karlström R, Peterson CG, Venge P. Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596 [Abstract] [Full Text] [Related]
16. Serum eosinophil cationic protein and bronchial hyperresponsiveness to hypoosmolar challenge in naive atopic asthmatics. Dal Negro R, Tognella S, Micheletto C, Pomari C, Burti E, Mauroner L, Turco P. J Investig Allergol Clin Immunol; 1998 May; 8(5):294-9. PubMed ID: 9827426 [Abstract] [Full Text] [Related]
17. Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma? Koller DY, Halmerbauer G, Frischer T, Roithner B. Clin Exp Allergy; 1999 Jun; 29(6):786-93. PubMed ID: 10336595 [Abstract] [Full Text] [Related]
18. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal. Lönnkvist K, Hellman C, Lundahl J, Halldén G, Hedlin G. J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347 [Abstract] [Full Text] [Related]
19. [Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children]. Stelmach I, Grzelewski T, Stelmach W, Majak P, Jerzyńska J, Górski P, Kuna P. Pol Merkur Lekarski; 2002 Mar; 12(69):208-13. PubMed ID: 12053590 [Abstract] [Full Text] [Related]
20. Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up. Belda J, Giner J, Casan P, Sanchis J. Chest; 2001 Apr; 119(4):1011-7. PubMed ID: 11296162 [Abstract] [Full Text] [Related] Page: [Next] [New Search]